As of 3:59pm ET
| -0.04 / -0.68%|
The 3 analysts offering 12-month price forecasts for Arrowhead Pharmaceuticals Inc have a median target of 9.00, with a high estimate of 13.00 and a low estimate of 4.00. The median estimate represents a +54.11% increase from the last price of 5.84.
The current consensus among 3 polled investment analysts is to Hold stock in Arrowhead Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.